Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials

Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials

Background: The best response and survival outcomes between advanced melanoma patients treated with the anti-PD-1 monotherapy vary greatly, rendering a risk model in need to optimally stratify patients based on their likelihood to benefit from the said treatment.Methods: We performed an ad hoc analy...

Full description

Bibliographic Details
Main Authors: Xue Bai, Jie Dai, Caili Li, Chuanliang Cui, Lili Mao, Xiaoting Wei, Xinan Sheng, Zhihong Chi, Xieqiao Yan, Bixia Tang, Bin Lian, Xuan Wang, Li Zhou, Siming Li, Yan Kong, Zhonghui Qi, Huayan Xu, Rong Duan, Jun Guo, Lu Si
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
PD-1
melanoma
progression free survival
overall survival
best response
risk model
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.639085/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.639085/full

Similar Items